FATE: Fate Therapeutics Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Institutional ownership (Q2 2026)
156 institutions reported holding $178.07M of Fate Therapeutics Inc on Form 13F (158 the quarter before). 31 opened a new position and 30 sold out. Shares held by institutions: -5%.
| Largest holders | Shares | Value |
|---|---|---|
| Redmile Group, LLC | 12,872,946 | $34.76M |
| BlackRock, Inc. | 7,298,895 | $19.71M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,545,893 | $12.27M |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,445,536 | $12.00M |
| AQR CAPITAL MANAGEMENT LLC | 3,837,229 | $10.36M |
| TWO SIGMA INVESTMENTS, LP | 3,589,863 | $9.69M |
| JOHNSON & JOHNSON | 3,379,064 | $9.12M |
| RENAISSANCE TECHNOLOGIES LLC | 2,983,268 | $8.05M |
| MILLENNIUM MANAGEMENT LLC | 2,433,978 | $6.57M |
| GOLDMAN SACHS GROUP INC | 2,049,187 | $5.53M |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.